Annual Neuropsychiatric Drug Development Summit

Annual Neuropsychiatric Drug Development Summit the industry's premier gathering, showcasing the latest circuit-based target innovation, EEG and digital biomarker data, in vivo and in vitro model advances, pioneering precision psychiatry approaches and more. Join discovery, preclinical, translational, clinical, regulatory, and commercial experts from Karuna, Janssen, AbbVie, Otsuka, Sage Therapeutics, Lykos, Lundbeck, Compass, Biogen, Delix Therapeutics, and more as they address biopharma's most pressing challenges in a collaborative atmosphere to accelerate the race to approval for transformative neuropsychiatric candidates.